- AMC
- Tata Mutual Fund
- Category
- Sectoral/ Thematic
- ISIN
- INF277K018A5
Tata India Pharma & Healthcare Fund
₹29.7399
−₹0.3074 (−1.02%)
NAV · Regular · IDCW (Reinvestment) ·
Tata India Pharma & Healthcare Fund's Regular IDCW (Reinvestment) NAV was ₹29.7399 on 19 Oct 2026, down 1.02% on the day. Its 3-year return is 13.75% a year.
- Expense ratio
- 2.32%
- Fund size
- ₹1,358.76 Cr
- Min. investment
- ₹5,000
NAV history
Between 20 Oct 2025 and 19 Oct 2026, the NAV ranged from ₹27.9130 to ₹32.7005.
Regular · IDCW (Reinvestment) plan. 3Y, 5Y and since-launch returns are annualised; since launch is absolute until the fund is a year old.
Fund details
- Expense ratio
- 2.32% (Regular)
- Exit load
- 0.25% of nav if redeemed/switched out before 30 days from allotment date
- Riskometer
- Very high
- Benchmark
- BSE Healthcare TRI
- Launched
- 4 Dec 2015
- Fund managers
- Rajat Srivastava
Fund size, expense ratio and minimums as of 16 Oct 2026.
All plans
| Plan | ISIN | NAV | 1 day | Expense ratio | 1 year |
|---|---|---|---|---|---|
| Direct · Growth | INF277K019A3 | ₹36.6164 | −1.01% | 1.00% | +1.20% |
| Regular · Growth | INF277K016A9 | ₹30.9230 | −1.02% | 2.32% | −0.23% |
| Direct · IDCW (Payout) | INF277K010B0 | ₹35.4262 | −1.01% | — | −2.09% |
| Direct · IDCW (Reinvestment) | INF277K011B8 | ₹35.4262 | −1.01% | 1.00% | −2.09% |
| Regular · IDCW (Payout) | INF277K017A7 | ₹29.7399 | −1.02% | — | −4.05% |
| Regular · IDCW (Reinvestment) | INF277K018A5 | ₹29.7399 | −1.02% | 2.32% | −4.05% |
All plans hold the same portfolio. They differ in expense ratio (Direct plans pay no distributor commission) and in how gains are handled (Growth reinvests, IDCW pays out).
Armor risk check
Tata India Pharma & Healthcare Fund moves about as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appAbout this fund
Tata India Pharma & Healthcare Fund is an open-ended mutual fund from Tata Mutual Fund, in the Sectoral/ Thematic category. It began on 4 Dec 2015. It is benchmarked to the BSE Healthcare TRI. The fund manages ₹1,358.76 Cr across its plans as of 16 Oct 2026. The Regular · IDCW (Reinvestment) plan has an expense ratio of 2.32%. The minimum first investment is ₹5,000, and SIPs are available.
FAQs
What is the NAV of Tata India Pharma & Healthcare Fund?
The NAV of Tata India Pharma & Healthcare Fund (Regular · IDCW (Reinvestment)) was ₹29.7399 on 19 Oct 2026, down 1.02% from the previous NAV.
What plans does Tata India Pharma & Healthcare Fund have?
Tata India Pharma & Healthcare Fund has 6 plans: Direct · Growth; Regular · Growth; Direct · IDCW (Payout); Direct · IDCW (Reinvestment); Regular · IDCW (Payout); Regular · IDCW (Reinvestment).
What is the expense ratio of Tata India Pharma & Healthcare Fund?
The Regular · IDCW (Reinvestment) plan of Tata India Pharma & Healthcare Fund has an expense ratio of 2.32%.
What is the fund size (AUM) of Tata India Pharma & Healthcare Fund?
Tata India Pharma & Healthcare Fund manages ₹1,358.76 Cr across all plans as of 16 Oct 2026.
What returns has Tata India Pharma & Healthcare Fund delivered?
Tata India Pharma & Healthcare Fund returned −4.05% over 1Y, +13.75% a year over 3Y, +10.98% a year over 5Y. Past performance does not guarantee future returns.
What is the exit load of Tata India Pharma & Healthcare Fund?
Tata India Pharma & Healthcare Fund: 0.25% of nav if redeemed/switched out before 30 days from allotment date.
What is the minimum investment and SIP amount for Tata India Pharma & Healthcare Fund?
The minimum first investment in Tata India Pharma & Healthcare Fund is ₹5,000, and ₹1,000 after that. SIPs are available (SIP available with frequencies: Monthly/Quarterly/Weekly/Daily. Minimum amount Rs. 100 with multiples of Re. 1. Minimum instalments range from 4 to 12 based on frequency.).
How risky is Tata India Pharma & Healthcare Fund?
Tata India Pharma & Healthcare Fund is rated "very high risk" on SEBI's riskometer.
For information only. Not investment advice or a research report. Past performance does not guarantee future returns. Mutual fund investments are subject to market risks; read all scheme-related documents carefully.
Full disclaimerSee how Tata India Pharma & Healthcare Fund fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app